RxDoctor Payments Data

Rachael Harris Sprunger, DO

Physical Medicine & Rehabilitation · South Bend, INNPI 1457611865

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (57.1%), travel and lodging and education — rather than concentrated in one kind of arrangement. Nevro Corp. accounts for 66.5% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2019 at $2,351 and has fallen 79.9% since, to $472 in 2025.

$4,701in general payments, 2019–2025

Across 112 payments — averaging $41.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Nevro Corp.$3K
  • Boston Scientific$485
  • Medtronic$446
  • Globus Medical$346
  • AbbVie$188
  • Stryker$44
  • plus $65 from 4 others
$109,356in ownership & investment interests, 2019–2025

Across 7 payments — averaging $15,622 each. An ownership or investment interest held by the physician or an immediate family member.

  • Digital Diagnostics Inc.$109K

What the payments were for

  • Travel & lodging$2,00343%
  • Food & beverage$2,68557%
  • Education$140%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,701 in reported general payments places this provider in the 85th percentile of 140 physical medicine & rehabilitation providers in Indiana.

See all physical medicine & rehabilitation providers in Indiana

Medicare billing

Part B allowed, 2024
$134,827
Medicare patients
345
Services billed
2,261

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Duloxetine Hcl303$6,091
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen184$4,316
Pregabalin84$4,065
Gabapentin221$3,371
Tizanidine Hcl116$1,689
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen63$1,464
Oxycodone Hcl38$686
Methylprednisolone107$680
Amitriptyline Hcl17$609
Morphine Sulfate ErMorphine Sulfate21$459
Diclofenac Sodium25$389
Meloxicam110$363
Tramadol Hcl67$338
Baclofen15$193
Cyclobenzaprine Hcl18$103

Paid to pharmacies, not to this prescriber.

Other physical medicine & rehabilitation in South Bend

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →